Use of recombinant plasma kallikrein inhibitor in hereditary angioedema: a case report and review of the management of the disorder.
Turner
Michael D
MD
Department of Oral and Maxillofacial Surgery, NYU College of Dentistry, Bellevue Hospital, New York, NY 10010-4086, USA. mdt4@nyu.edu
Oughourli
Amina
A
Heaney
Kevin
K
Selvaggi
Thomas
T
D000799:Angioedema / Q000235:genetics / Q000628:therapy*; D001803:Blood Transfusion; D003174:Complement C1 Inactivator Proteins / Q000172:deficiency / Q000627:therapeutic use*; D017742:Dental Care for Chronically Ill; D005260:Female; D030342:Genetic Diseases, Inborn; D006801:Humans; D008875:Middle Aged; D010949:Plasma; D020842:Plasma Kallikrein / Q000037:antagonists & inhibitors*; D011292:Premedication; D011994:Recombinant Proteins / Q000627:therapeutic use; D014081:Tooth Extraction / Q000379:methods*
D003174:Complement C1 Inactivator Proteins; D011994:Recombinant Proteins; D020842:Plasma Kallikrein